Celldex Therapeutics received a Buy rating upgrade from H.C. Wainwright, with the price target raised to $64 from $42, following successful Phase 3 clinical trials of barzolvolimab. The drug showed rapid and lasting benefits for patients with a chronic skin condition not well-controlled by antihistamines. Nearly 2,000 patients across 43 countries participated in the trials, which met all primary goals. Celldex plans to submit for FDA approval in 2027, signaling significant progress in its drug development pipeline.
Celldex Therapeutics and its recent analyst upgrade provide context for health-sector activity on Pluang. For readers following health stocks, 78 of 101 priced US health-sector stocks rose today. Notable movers include Aurora Cannabis Inc (ACB) at USD 4.22 with a 4.84% increase, Amgen, Inc. (AMGN) at USD 410.00 with a 4.28% increase, and Recursion Pharmaceuticals Inc (RXRX) at USD 4.13 with a 4.16% increase. These figures are as of Sep 23, 2026 02:01 WIB.
OpenAI's new GPT-6 Astra model can operate legacy banking systems by reading screens and inputting data like a human, offering banks a faster, cheaper alternative to replacing decades-old core systems. These legacy systems, often written in COBOL, ar...
Physical attacks on Bitcoin holders have increased significantly, especially in France, which leads in reported incidents. The rise correlates with Bitcoin's price rally, raising security risks for crypto owners. Data leaks and mandatory information ...
Royal Caribbean is close to securing a $3 billion deal to acquire a 50% equity stake in Sandals, valuing the Caribbean resort chain at $6 billion. This move aims to expand Royal Caribbean's presence in land-based vacations, complementing its cruise b...
Moov has introduced Moov Money, a real-time peer-to-peer payment service developed with Visa and Mastercard. This solution allows users to send and receive money through their digital banking provider using any eligible Visa or Mastercard debit card,...
Sui has introduced GraphQL subscriptions on its Mainnet, enabling developers to stream real-time blockchain data such as checkpoints, transaction blocks, and events through a single WebSocket interface. This upgrade replaces the older JSON-RPC system...
